Hakumei Oh

1.5k citations
15 papers · 1.1k indexed · 1 hit paper · h-index 8

Hakumei Oh

15 papers receiving 1.0k citations

Hit Papers

Prognostic implication of FLT3 and N-RAS gene mutations i...6201999202620082017200400600

Peers

Hakumei Oh
Comparison fields: 5 of 66
  • Hematology 849
  • Genetics 221
  • Oncology 305
  • Public Health, Environmental and Occupational Health 213
  • Emergency Medicine 56
Replace M Gyger with:
M Gyger Canada
S. Faderl United States
Marino Clavio Italy
B Barlogie United States
Eros Di Bona Italy
WJ Miller United States
DC Young United States
S N Rabinowe United States
F. R. Appelbaum United States
Athanasios Zomas Greece
Hakumei Oh relative to M Gyger Canada M Gyger's profile →
Citations per field
00.5×1.5×2.1×
M Gyger · 1×
Citations per year

Countries citing papers authored by Hakumei Oh

Since Specialization
Citations

This map shows the geographic impact of Hakumei Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakumei Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakumei Oh more than expected).

Fields of papers citing papers by Hakumei Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakumei Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakumei Oh. The network helps show where Hakumei Oh may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hakumei Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hakumei Oh Line = papers co-authored together Hakumei Oh links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 20004
2 200098
3
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.breakdown →
1999620
4 199713
5 19964
6 199521
7 199517
8 19942
9 19935
10 19932
11 19927
12 1990281
13 19891
14 19897
15 19881

About Hakumei Oh

Hakumei Oh is a scholar working on Hematology, Hepatology and Immunology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Retinoids in leukemia and cellular processes (2 papers), Hematological disorders and diagnostics (2 papers), Glycosylation and Glycoproteins Research (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Hematology (849 citations), Genetics (221 citations) and Oncology (305 citations). Hakumei Oh has collaborated with scholars based in Japan, United States and Kenya. Frequent co-authors include Ryuzo Ohno, Kenji Saito, Norio Asou, Shuichi Miyawaki, Kazutaka Kuriyama, Hideki Akiyama, Hidehiko Saito, Toshiko Motoji, Saburo Minami and Ryuzo Ueda. Their work appears in journals such as American Journal of Hematology, Blood, British Journal of Haematology, Cancer and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026